同: chylomicrons

WordNet

a microscopic particle of triglycerides produced in the intestines during digestion; in the bloodstream they release their fatty acids into the blood

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/11/17 13:13:38」(JST)

wiki en

Schematic image showing a chylomicron

Chylomicrons (from the Greek chylo, meaning juice or milky fluid, and micron, meaning small particle) are lipoprotein particles that consist of triglycerides (85–92%), phospholipids (6–12%), cholesterol (1–3%), and proteins (1–2%).^[1] They transport dietary lipids from the intestines to other locations in the body. Chylomicrons are one of the five major groups of lipoproteins (chylomicrons, VLDL, IDL, LDL, HDL) that enable fats and cholesterol to move within the water-based solution of the bloodstream.

Function

Chylomicron structure

ApoA, ApoB, ApoC, ApoE (apolipoproteins); T (triacylglycerol); C (cholesterol); green (phospholipids)

Chylomicrons transport lipids absorbed from the intestine to adipose, cardiac, and skeletal muscle tissue, where their triglyceride components are hydrolyzed by the activity of lipoprotein lipase and the released free fatty acids are absorbed by the tissue. When a large portion of the triacylglycerol core have been hydrolyzed, chylomicron remnants are formed and are taken up by the liver, hereby transferring dietary fat also to the liver.

Origin

Chylomicrons are formed in the endoplasmic reticulum in the absorptive cells of small intestines. To be specific, the mucosal cells within the villi of the duodenum. Newly formed chylomicrons are secreted through the baso-lateral membrane into the lymphatic system. Chylomicrons are released from the lymph to the blood systems, and supply the tissue with fat absorbed from the diet.^[2]

Stages

There are three stages in the chylomicron's "lifecycle":

Nascent chylomicron
Mature chylomicron
Chylomicron remnant

Nascent chylomicrons

Triglycerides are emulsified by bile and hydrolyzed by the enzyme lipase, resulting in a mixture of fatty acids and monoglycerides. These then pass from the intestinal lumen into the enterocyte, where they are re-esterified to form triacylglycerol. The triacylglycerol is then combined with phospholipids, cholesterol ester, and apolipoprotein B-48 to form a nascent chylomicrons. These are then released by exocytosis from enterocytes into lacteals, lymphatic vessels originating in the villi of the small intestine, and are then secreted into the bloodstream at the thoracic duct's connection with the left subclavian vein.

Nascent chylomicrons are composed primarily of triglycerides (85%) and contain some cholesterol and cholesteryl esters. The main apolipoprotein component is apolipoprotein B-48 (apo B-48).

Mature chylomicron

While circulating in blood, chylomicrons exchange components with high-density lipoproteins (HDL). The HDL donates apolipoprotein C-II (APOC2) and apolipoprotein E (APOE) to the nascent chylomicron and, thus, converts it to a mature chylomicron (often referred to simply as "chylomicron"). APOC2 is the cofactor for lipoprotein lipase (LPL) activity.

Chylomicron remnant

Once triglyceride stores are distributed, the chylomicron returns APOC2 to the HDL (but keeps APOE), and, thus, becomes a chylomicron remnant, now only 30–50 nm. APOB48 and APOE are important to identify the chylomicron remnant in the liver for endocytosis and breakdown.

References

^ M Mahmood Hussain: "Review Article: A proposed model for the assembly of chylomicrons"; Arterosclerosis; Vol. 148; 2000; pages 1–15;
^ Smith, Sareen S. Gropper, Jack L.; Smith, Jack S (2013). Advanced nutrition and human metabolism (6th ed.). Belmont, CA: Wadsworth/Cengage Learning. ISBN 1133104053.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. リポ蛋白の分類、代謝、およびアテローム性動脈硬化症における役割 lipoprotein classification metabolism and role in atherosclerosis
2. 乳糜胸症の病因、臨床像、および診断 etiology clinical presentation and diagnosis of chylothorax
3. 乳糜胸症のマネージメント management of chylothorax
4. 乳糜胸症の臨床像、診断、およびマネージメント clinical presentation diagnosis and management of cholesterol effusions
5. 小児における慢性下痢の原因の概要 overview of the causes of chronic diarrhea in children

English Journal

Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.

Kohan AB1.
Current opinion in endocrinology, diabetes, and obesity.Curr Opin Endocrinol Diabetes Obes.2015 Apr;22(2):119-25. doi: 10.1097/MED.0000000000000136.
PURPOSE OF REVIEW: The purpose of this article is to summarize the recent epidemiological, basic science, and pharmaceutical research linking apolipoprotein C-III (apoC-III) with the development and treatment of cardiovascular disease (CVD).RECENT FINDINGS: ApoC-III is an important emerging target l
PMID 25692924

Can Genetic Variability in α-Tocopherol Bioavailability Explain the Heterogeneous Response to α-Tocopherol Supplements?

Borel P1, Desmarchelier C, Nowicki M, Bott R, Tourniaire F.
Antioxidants & redox signaling.Antioxid Redox Signal.2015 Mar 10;22(8):669-78. doi: 10.1089/ars.2014.6144. Epub 2014 Nov 12.
Both vitamin E (VE) consumption and blood VE status have been negatively associated with the incidence of degenerative diseases and some cancers. However, the response to VE supplementation is very variable among individuals. This could be due to interindividual variability in VE bioavailability, du
PMID 25289663

Role of Conserved Proline Residues in Human Apolipoprotein A-IV Structure and Function.

Deng X1, Walker RG1, Morris J1, Davidson WS1, Thompson TB2.
The Journal of biological chemistry.J Biol Chem.2015 Mar 2. pii: jbc.M115.637058. [Epub ahead of print]
Apolipoprotein (apo)A-IV2 is a lipid emulsifying protein linked to a range of protective roles in obesity, diabetes and cardiovascular disease. It exists in several states in plasma including lipid-bound in high density lipoproteins (HDL) and chylomicrons and as monomeric and dimeric lipid-free/poor
PMID 25733664